FDA Investigator Tyanna N Hadley

Tyanna N Hadley has inspections in 3 countries as of 21 Dec 2023. Tyanna N Hadley has collaborated with a combinined 1849 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
35
Last Inspection Date:
21 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Switzerland
Co-Investigator(s):
Addam S Reynolds, Alberto A Viciedo, Alice S Tsao, Allen Lou, Amy A Johnson, Amy L Singer, Anastasia I Offordile, Anna Kevilag, Anna Kwilas, Annemarie Bodnar, Anthony Kovalenko, Asia D Clark, Bijoy Panicker, Byungja E Marciante, Byunja E Marciante, Charles J Chacko, Cheryl A Grandinetti, Christina N Maurino, Christopher Janik, Cody D Rickman, Darin S Wiegers, David H Smith, Dawn L Wydner, Deborah B Nixon, Demitria J Xiradakis, Denise M Visco, Investigator, Diane C Thibodeau, Dien N Nguyen, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, E Marciante, Eduardo L Rodriguez, Emest F Bizjak, Emily A Walters, Emmanuel J Ramos, Eric Rothschild, Erin D Mccaffery, Feiyan Jin, Gam S Zamil, George Pyramides, Guerlain Ulysse, Haley H Seymour, Helen B Ricalde, Jay T Wong, Jean Blackston Hill, Jean M Kelahan, Joan A Loreng, Joanne M Schlossin, Jonee J Mearns, Jose M Cayuela, Joy P Matthias, Justine Tomasso, Karen E D'orazio, Karen L Kosar, Kassa Ayalew, MD, Kathleen B Swat, Kelli F Dobilas, Kent A Conforti, Kimberly L Schultz, Kristy A Zielny, Lata C Mathew, PhD, Leon L Crawley, Liatte Kreuger, PharmD, Linda Thai, Lisa Harlan, Loretta Nemchik, M Patriciaurphy Murphy, Marcelo O Mangalindan, Jr, Margaret M Sands, Mark R Mcclain, Matthew A Spataro, Maya M Davis, Mayar M Mussa, Melissa T Roy, Meredith L Sheridan, Michael R Klapal, Michael Serrano, Michael Skelly, Michelle A Marsh, Nerizza B Guerin, Nicholas A Violand, Nimmy Mathews, Nina Yang, Paul E Stein, Paul L Bellamy, Peter R Lenahan, Regina T Brown, Robert G Ruff, Robert W Jennings, Rodney T Allnutt, Ruth A Williams, Sandra Kershaw, Satheesh Thomas, Shirley S Wen, Simone E Pitts, Sony Mathews, Srinivas R Chennamaneni, PhD, Stephanie T Durso, Stephen J Mottola, Stephen R Souza, Tanya R Syffrard, Tonia F Bernard, Tynna N Hadley, Unnee Ranjan, Yangmin Ning, Yvesna C Blaise

Tyanna N Hadley's Documents

Publish Date Document Type Title
October, 2021 FDA 483 Aquestive Therapeutics Inc. - Form 483, 2021-10-07
March, 2023 EIR SpringWorks Therapeutics, Inc. - EIR, 2023-03-31
October, 2021 EIR Mitsubishi Tanabe Pharma Development America, Inc. - EIR, 2021-10-15
October, 2021 FDA 483 Mitsubishi Tanabe Pharma Development America, Inc. - Form 483, 2021-10-15
January, 2022 EIR BioClinica, Inc. - EIR, 2022-01-10
March, 2023 FDA 483 Ferring Pharmaceuticals Inc - Form 483, 2023-03-14
August, 2022 FDA 483 Eli L. Diamond, MD - Form 483, 2022-08-24
November, 2021 FDA 483 Ascend Laboratories, LLC - Form 483, 2021-11-10
November, 2021 EIR Ascend Laboratories, LLC - EIR, 2021-11-10
August, 2023 FDA 483 Novartis Pharmaceuticals Corporation - Form 483, 2023-08-21
March, 2023 FDA 483 SpringWorks Therapeutics, Inc. - Form 483, 2023-03-31
March, 2022 FDA 483 BioClinica, Inc. - Form 483, 2022-03-04
October, 2021 EIR Aquestive Therapeutics Inc. - EIR, 2021-10-07
June, 2023 FDA 483 Cassie L. Blanchard, PhD - Form 483, 2023-06-13
February, 2023 FDA 483 AtlantiCare Regional Medical Center IRB - Form 483, 2023-02-23
March, 2022 EIR CELGENE CORPORATION - EIR, 2022-03-14
September, 2022 FDA 483 Ascent Pharmaceuticals Inc - Form 483, 2022-09-15
April, 2022 FDA 483 Inci B. Yildirim, M.D. - Form 483, 2022-04-15
September, 2022 EIR Ascent Pharmaceuticals Inc - EIR, 2022-09-15
May, 2022 FDA 483 Dr. Reddy's Laboratories, Inc. - Form 483, 2022-05-26
July, 2023 FDA 483 Suneet Mittal, MD - Form 483, 2023-07-11
June, 2023 FDA 483 Michael A. Hassman, DO - Form 483, 2023-06-20
October, 2023 FDA 483 Purdue Pharma L.P. - Form 483, 2023-10-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more